Zepbound (tirzepatide) should be stopped at least one month before attempting pregnancy. The drug is not approved for use during pregnancy, and the manufacturer advises a washout period to ensure clearance. On the other hand, the substantial weight loss Zepbound delivers may significantly improve fertility for patients with obesity-linked reproductive difficulties.

Zepbound is the weight management formulation of tirzepatide, a dual GIP/GLP-1 receptor agonist. Given that it is prescribed primarily to patients with a BMI of 30 or higher, many of its users are in demographics where fertility planning is a relevant concern.

Discontinuation Timeline for Pregnancy Planning

Tirzepatide has a half-life of roughly five days. After stopping Zepbound, the drug is considered substantially cleared from the body within about four weeks (roughly five to six half-lives). The prescribing information recommends stopping at least one month before planned conception.

Animal studies conducted at supratherapeutic doses revealed adverse developmental outcomes, including reduced fetal weight and skeletal variations. Human pregnancy data remains extremely limited because pregnant patients are excluded from clinical trials. The one-month washout provides a reasonable safety margin based on the drug's pharmacokinetics.

Fertility Benefits of Zepbound-Assisted Weight Loss

Clinical trials for tirzepatide showed weight loss averaging 15% to 25% of starting body weight, among the highest of any medication currently available. For patients whose fertility is impaired by excess weight, this degree of reduction can be genuinely life-changing:

• Ovulation may resume in women who had stopped ovulating due to obesity or PCOS
• Hormone profiles normalize as excess adipose tissue decreases
• IVF and IUI success rates improve at lower body weight
• Pregnancy complications like gestational diabetes and hypertension become less likely
• Male partners benefit from improved testosterone and sperm quality after weight loss

Unexpected Pregnancies and Contraception

As with other GLP-1 medications, weight loss on Zepbound can restore ovulatory function in women who previously had irregular or absent periods. This has led to unplanned pregnancies in patients who did not expect to conceive. If pregnancy is not your goal, use dependable contraception throughout treatment.

Zepbound's prescribing information specifically notes that it may affect oral contraceptive absorption due to delayed gastric emptying. Patients using oral birth control are advised to add a backup method for four weeks after initiating Zepbound and for four weeks after each dose increase. Non-oral methods like IUDs, implants, and contraceptive injections are not impacted.

Frequently Asked Questions